TrialBMC cancer2025

Radiotherapy quality assurance program of ongoing clinical trial using stereotactic ablative radiation therapy for recurrent ovarian cancer (SABR-ROC): a dummy run study of a prospective, randomized, multicenter phase III trial (KGOG 3064/KROG 2204).

Sangjoon Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.